As of 4:00pm ET
| -0.76 / -3.41%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 26.50, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a +22.97% increase from the last price of 21.55.
The current consensus among 4 polled investment analysts is to Hold stock in Enanta Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.